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Letters to the Editor 409on the right hip and nausea. Physical examination revealed
that her temperature was 37.7 8C. The brucella agglutina-
tion test was positive at a titer of 1/640. Blood cultures
were sterile. It was thought to be a relapse of brucellosis
and was treated with streptomycin for three weeks and
for eight weeks with rifampin and doxycycline. Following
this oral therapy, she had physiotherapy and recovered
completely.
Case C. Her 52-year-old husband presented with com-
plaints of high fever, rigors, sweating and pain in the lumbar
region for seven days. He had a temperature of 36.5 8C. The
brucella agglutination titer was 1/320. Blood cultures were
sterile. He was treated for six weeks with doxycycline and
rifampin.
Case D. Her 24-year-old son came to hospital with a
ten-day history of fever, rigors and sweating. He had a
temperature of 37.5 8C. The brucella agglutination titer
was 1/640; blood culture was sterile. He was treated for
six weeks with doxycycline and rifampin.
At review, twelve months after treatment, all patients
remained well.
Brucellosis in members of the same family has been
reported previously.1—4 As brucellosis was determined in
all the family members within a one-month period, a
common source was investigated. The family did not w
ork with animals and they were not used to eating cheese
made from raw milk. Three kinds of cheese that the
family had ingested were cultured but the results were
negative for Brucella spp. Although sexual transmission is
possible between parents of this family, as all the members
were infected, a common source of food was thought to be
the cause.
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doi:10.1016/j.ijid.2005.06.010An unusual presentation of acute brucellosis
with fever, jaundice and maculopapular rash
The clinical features of brucellosis are diverse.1 An uncom-
mon case of brucellosis with the triple conditions of fever,
jaundice and maculopapular rash is described.
A 35-year-old male farmer was admitted to our clinic
because of a seven-day history of fever, jaundice, general-
ized myalgia, fatigue, vomiting, anorexia, sweating and a
maculopapular rash that had appeared one day before
admission. The rash covered the trunk, arms and legs.
Physical examination revealed fever of 39 8C, tachycardia
of 110/min, and blood pressure of 110/90 mmHg. He
had jaundice, rash and hepatosplenomegaly. Laboratory
findings were: white cell count: 6.2  109/L, hematocrit:
37%, platelet count: 45  109/L, erythrocyte sedimentation
rate: 8 mm/h, and C-reactive protein: 7.4 mg/dL (0—
0.5 mg/dL). Biochemical parameters were BUN: 27 mg/dL
(5—23 mg/dL), creatinine: 1.7 mg/dL (0.8—1.4 mg/dL),
total bilirubin: 5.9 mg/dL (0.25—1.2 mg/dL), direct
bilirubin: 2.8 mg/dL (0—0.2 mg/dL), alkaline phosphatase:
502 U/L (64—300 U/L), AST: 486 U/L (10—37 U/L), ALT:
363 U/L (10—37 U/L), and LDH: 3320 U/L (220—450
U/L).Urinalysis revealed a positive result for both protein and
bilirubin. Diffuse enlargement of the spleen and liver were
detected on abdominal ultrasound examination. A chest
X-ray was normal. Antinuclear antibodies, anti-DNA, tuber-
culin skin test, parasitic examinations, and serologic tests
for syphilis, salmonellosis, leptospirosis, rickettsiae, myco-
plasma, toxoplasma, cytomegalovirus, Epstein—Barr virus,
herpes simplex virus, human immunodeficiency virus and
hepatitis B and C viruses were negative. A skin biopsy was
not performed. On admission, a Wright agglutination test
was negative, but after four days, seroconversion at a titer
of 1/320 occurred. One week after hospitalization, blood
and bone marrow cultures for Brucella species were posi-
tive by the BACTEC technique. Doxycycline (200 mg/day)
and streptomycin (1 g/day) were started. The rash disap-
peared within four days of therapy commencement, and
fever resolved on the sixth day of therapy. Antibiotic
therapy continued for six weeks (doxycycline for six weeks
and streptomycin for three weeks). At the 24-week follow
up, the patient had made a full clinical and biochemical
recovery.
Brucellosis is a multi-system disease with a broad spec-
trum of non-specific symptoms that generally occur within
two weeks (but sometimes up to three months) after infec-
tion. Because the clinical illness is nonspecific, a complete
410 Letters to the Editorhistory, including a detailed dietary history, is crucial. The
most common route of transmission is ingestion of raw milk
products from diseased animals.
The patient was a shepherd and reported consuming
cheese made from raw milk. He had many acute signs and
symptoms of human brucellosis, i.e., fever, myalgia, anor-
exia, fatigue, sweats and lumbar pain, and other clinical
manifestations such as splenomegaly and hepatomegaly, and
also rare manifestations such as rash and jaundice.
Cutaneous lesions occur in about 5—15% of patients with
brucellosis.2,3 A variety of rarely-reported skin lesions has
been described in brucellosis, including maculopapular
lesions, papules, petechiae, purpura, impetiginous and
psoriform lesions.4 The cutaneous findings observed in
brucellosis are due to direct inoculation, hypersensitivity
phenomena, deposition of immune complexes, and direct
invasion by the organism reaching the skin hematogenously.
Berger et al.2 have separated the cutaneous lesions in
brucellosis into those of exogenous and endogenous char-
acter. Those of exogenous character include brucellar der-
matitis and primary inoculation abscess. Ariza et al.5
divided endogenous cutaneous lesions into four different
groups: disseminated papulonodular eruption, erythema
nodosum-like, extensive purpura, and diffuse maculopap-
ular eruption. Diffuse maculopapular eruption was reported
in three patients in the study of Ariza et al.5 and in one
patient in the study of Ural and Fındık.6
Splenomegaly or hepatomegaly is found in 20 to 30% of
cases. Liver and spleen enlargement with mild nonspecific
elevation of liver enzyme levels can be detected in approxi-
mately 50% of patients with brucellosis.7 The spectrum of
pathologic findings in brucellar hepatitis is varied. Infection
with Brucella abortus is characterized by granulomas. By
contrast, infection with Brucella melitensis produces
lesions ranging from small aggregates of mononuclear cells
surrounding foci of necrosis scattered throughout the par-
enchyma to a diffuse nonspecific inflammation.8
Skin involvement is uncommon in human brucellosis. While
hepatitis is common, it is usually subclinical and jaundice is
rare. This is an unusual case of brucellosis where a patient
showed triple symptoms of fever, jaundice andmaculopapular
rash, and is reported here to remind physicians of the rare
complications of brucellosis; the disease is capable of devel-
oping unexpected complications in unusual organs.Conflict of interest: No conflict of interest to declare.
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doi:10.1016/j.ijid.2005.06.004A fatal case of measles pneumonia complicating
an adult recipient of hemopoietic stem cell
transplantation during the nationwide epidemic
in Korea
In 2000—2001, a measles (rubeola) epidemic occurred
in Korea, with more than 55 000 reported cases.1 During
the outbreak, a total of 16 transplant recipients in our
hemopoietic stem cell transplantation (HSCT) center
were presumptively diagnosed with measles.2 There
have been several reports published on patients who
have developed severe complications after contracting
measles,3—5 most of which refer to children with either
a malignancy or HIV infection. However, measles compli-cations in adults who have received HSCT have rarely been
reported.
A 39-year-old woman was hospitalized for complaints of
diffuse abdominal pain and diarrhea of 3 days’ duration. The
patient had previously been diagnosed to be in the chronic
phase of chronic myelogenous leukemia, and had received an
HLA-matched sibling allogeneic HSCT with busulphan and
cyclophosphamide 15 months prior to this hospitalization.
She was on combined immunosuppressive therapy with
cyclosporin, prednisolone, and mycophenolate mofetil for
extensive chronic graft-versus-host disease (GVHD). There
was no history of a post-HSCT vaccination and no known
recent exposure to measles.
On day 2 of hospitalization she developed a fever, a cough,
and conjunctivitis, which were followed by a maculopapular
